PMID- 17254018 OWN - NLM STAT- MEDLINE DCOM- 20070718 LR - 20221207 IS - 0022-3042 (Print) IS - 0022-3042 (Linking) VI - 101 IP - 3 DP - 2007 May TI - Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. PG - 641-51 AB - In the present study, we used high-speed chronoamperometry to examine serotonin (5-HT) transporter (5-HTT) function in vivo in 2-, 5-, and 10-month-old brain-derived neurotrophic factor (BDNF)+/- mice. The rate of clearance of exogenously applied 5-HT was measured in CA3 region of hippocampus. In 2-month-old mice, the rate of 5-HT clearance did not differ between BDNF+/+ and BDNF+/- mice. In BDNF+/+ mice, 5-HT clearance rate (Tc) increased markedly with age. In contrast, Tc remained relatively static in BDNF+/- mice across 2-, 5-, and 10-month age groups. At 5 months of age, female BDNF+/+ mice had a lower maximal velocity (Vmax) for 5-HT clearance than male BDNF+/+ mice. There was a similar trend in 5-month-old BDNF+/- mice, but this did not reach statistical significance. There was an age-dependent increase in KT value for 5-HT clearance (i.e., decreased in vivo affinity of 5-HTT), but no significant effect of genotype or gender. 5-HTT density, as measured by [3H]cyanoimipramine binding, was not different between BDNF+/+ and BDNF+/- mice, although there was a significant increase in 5-HTT binding with age. The selective 5-HT reuptake inhibitor fluvoxamine (50 and 100 pmol) significantly decreased 5-HT clearance in BDNF+/+ mice, but not in BDNF+/- mice. Our data suggest that the profoundly reduced ability of 5- and 10-month-old BDNF+/- mice to clear 5-HT is not because of a decrease in the total number of 5-HTTs, but may be due to functional deficits in the 5-HTT, e.g., in the machinery/signaling required for insertion of 5-HTTs into the plasma membrane and/or activation of the 5-HTT once it is positioned to take up 5-HT from extracellular fluid. FAU - Daws, L C AU - Daws LC AD - Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. FAU - Munn, J L AU - Munn JL FAU - Valdez, M F AU - Valdez MF FAU - Frosto-Burke, T AU - Frosto-Burke T FAU - Hensler, J G AU - Hensler JG LA - eng GR - R01-MH52369/MH/NIMH NIH HHS/United States GR - R01-MH64489/MH/NIMH NIH HHS/United States GR - R21 MH071488/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070124 PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Serotonin Plasma Membrane Transport Proteins) RN - 0 (Serotonin Uptake Inhibitors) RN - 02MNR4P2PM (cianopramine) RN - 333DO1RDJY (Serotonin) RN - O4L1XPO44W (Fluvoxamine) RN - OGG85SX4E4 (Imipramine) SB - IM MH - Age Factors MH - Animals MH - Autoradiography/methods MH - Brain-Derived Neurotrophic Factor/deficiency/*physiology MH - Dose-Response Relationship, Drug MH - Electrochemistry/methods MH - Female MH - Fluvoxamine/pharmacology MH - Gene Expression/drug effects/*physiology MH - Hippocampus/drug effects/metabolism MH - Imipramine/analogs & derivatives/pharmacokinetics MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Protein Binding/drug effects MH - Serotonin/metabolism/pharmacology MH - Serotonin Plasma Membrane Transport Proteins/*physiology MH - Selective Serotonin Reuptake Inhibitors/pharmacology MH - Sex Factors EDAT- 2007/01/27 09:00 MHDA- 2007/07/19 09:00 CRDT- 2007/01/27 09:00 PHST- 2007/01/27 09:00 [pubmed] PHST- 2007/07/19 09:00 [medline] PHST- 2007/01/27 09:00 [entrez] AID - JNC4392 [pii] AID - 10.1111/j.1471-4159.2006.04392.x [doi] PST - ppublish SO - J Neurochem. 2007 May;101(3):641-51. doi: 10.1111/j.1471-4159.2006.04392.x. Epub 2007 Jan 24.